The Vault series

Insight on what matters - so you can transform your business.

16 Critical Attributes for a High M&A or Investment Valuation

04 May 2017

TECHNOLOGY SECTOR M&A GROWTH From April 2016 to April 2017 the tech sector has experienced more buoyant growth than it has seen in a decade*. SaaS, both vertical and horizontal, is up over 20%....

How to Choose a Contract Research Organization

28 April 2017

For the pharmaceutical industry, outsourcing to Contract Research Organizations (CROs) is an integral part in developing drugs. Both large pharma and smaller biotechs, who partner with CROs for...

The 4th Due Diligence Summit for Life Sciences

11 April 2017

  On May 18-19, 2017 ExL Events will host the 4th Due Diligence Summit for Life Sciences at the Hyatt Regency in Boston. This is the only life sciences event that is focused on the needs of...

ShareVault is proud to support Cure SMA and the organization’s dedication to the treatment and cure of Spinal Muscular Atrophy

03 April 2017

SMA (spinal muscular atrophy) is a disease that robs people of physical strength by affecting the motor nerve cells in the spinal cord, taking away the ability to walk, eat or breathe. It is the...

What to Consider when Choosing an M&A Advisor

23 March 2017

Because most people don’t usually have the expertise, contacts or time to sell their business, it's usually a bad idea for the entrepreneur selling a company to tackle the M&A market without help...

Microbiomes— Hope or Hype?

20 March 2017

Although we have long known about the existence of microbes—the tiny bacteria, fungi and archaea that live all around us, on us, and in us—interest in how the microbiome might impact human...

The Top 5 M&A Deals of 2016

01 March 2017

Distrust of big business around the world is on the rise, and perhaps for good reason. This skepticism was evident among voters in the U.S. during the 2016 election year and was a topic that...


07 February 2017

James C. Greenwood is President and CEO of the Biotechnology Innovation Organization (BIO) in Washington, D.C., which represents more than 1,200 biotechnology companies, academic institutions, state...


07 February 2017

Jim McCarthy is a Business Development Expert helping BioPharma companies plan their partnership strategies and due diligence. He knows how to W.I.N.  Vault Series: Jim, when companies are doing due...

The 10 Most Common Fallacies of Biopharma Partnering

31 January 2017

Today's biotech companies are increasingly recognizing the importance of aligning with strategic partners to advance their drug candidates to market. But how does the small biotech partner...

The Seven Habits of Highly Effective Data Rooms

View More

Popular Posts

Stay up to date on the latest industry tips and advice